Missed TTP: The rare diagnosis that became a malpractice nightmare

Few hematologic emergencies carry as high a stake as thrombotic thrombocytopenic purpura (TTP). 

Although rare, untreated TTP has a mortality rate approaching 90%, while prompt plasma exchange dramatically improves survival. ^[]

That makes delays in recognizing the syndrome a recurring theme in medical malpractice litigation.

What happened

A patient presented with clinical findings that, in hindsight, were highly suggestive of TTP. ^[] Despite progressive thrombocytopenia and evidence of microangiopathic hemolytic anemia, the diagnosis was not made early enough for timely initiation of plasma exchange therapy.

Expert witnesses argued that the combination of thrombocytopenia, hemolytic anemia, and evolving organ dysfunction should have immediately elevated TTP high on the differential diagnosis, prompting urgent hematology consultation and empiric treatment rather than waiting for confirmatory testing. 

A lawsuit alleged that the delay in diagnosis allowed the disease to progress, resulting in devastating neurologic injury and ultimately forming the basis for the malpractice claim.

As with many malpractice cases, the legal debate centered less on whether TTP is rare and more on whether clinicians appropriately recognized a time-sensitive emergency once the clinical picture began to emerge.

“We get labs on like anything that moves. Crazy not to get some on a lupus patient,” wrote Reddit user and DO @sergantsnipes05 about the case. 

Why TTP is so easy to miss

Most physicians may encounter only a handful of TTP cases (or none at all) during their careers.

The classic pentad of fever, neurologic symptoms, renal dysfunction, thrombocytopenia, and microangiopathic hemolytic anemia is uncommon at presentation, and waiting for all five findings can be dangerous.

Instead, many patients initially present with:^[]

• Severe thrombocytopenia

• Hemolytic anemia

• Elevated LDH

• Low haptoglobin

• Normal coagulation profile

• Variable neurologic complaints ranging from headache to confusion or stroke

Because these findings overlap with conditions such as immune thrombocytopenia, disseminated intravascular coagulation, sepsis, atypical hemolytic uremic syndrome (HUS), or even severe hypertension, diagnostic anchoring is an ever-present risk. ^[]

The malpractice lesson: Treat first, confirm later

One of the recurring themes in TTP litigation is that ADAMTS13 testing is not an emergency test. Results often take several days to return. ^[]

The accepted standard is generally to estimate clinical probability using tools such as the PLASMIC score and begin plasma exchange immediately when suspicion is high rather than waiting for laboratory confirmation. ^[]

Delaying treatment until the diagnosis is “proven” can be difficult to defend if the patient deteriorates.

What doctors can learn

1. Rare diseases still need a trigger point

No physician is expected to diagnose every rare disease instantly. What juries often examine, however, is whether clinicians recognized a pattern that required escalation.

A platelet count that continues to fall alongside evidence of hemolysis should trigger reconsideration of the differential rather than repeated reassurance that the patient has isolated thrombocytopenia.

2. Don’t wait for the entire clinical picture

The “classic pentad” remains memorable for board exams but is less useful clinically. Many patients never exhibit all five findings before treatment begins.

3. Consult hematology early

One of the strongest defenses in rare, rapidly evolving diseases is demonstrating appropriate escalation.

Early hematology involvement documents that the possibility of TTP was considered and allows plasma exchange arrangements to begin as quickly as possible.

4. Recognize that platelets can make things worse

Unlike many causes of thrombocytopenia, platelet transfusions in TTP are generally avoided unless there is life-threatening bleeding or an urgent invasive procedure, because they may worsen microvascular thrombosis. ^[]Recognizing this distinction is another reason that early diagnosis matters.

5. Document your evolving differential

Malpractice cases often benefit from hindsight. If TTP is considered but thought less likely, documenting the reasoning, the alternative diagnoses being pursued, repeat laboratory plans, and thresholds for escalation can help demonstrate thoughtful clinical decision-making.